|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,405 IDR | -1.75% |
|
+0.36% | -12.73% |
| Apr. 01 | PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 20 | Nomura Adjusts Kalbe Farma’s Price Target to IDR1,850 From IDR2,500, Keeps at Buy | MT |
PT Kalbe Farma Tbk. (IDX:KLBF) entered into agreement to acquire 80% stake in PT Aventis Pharma (Indonesia) from Hoechst GmbH and Sanofi-Aventis Participations S.A.S. on July 22, 2022. Transaction is expected to be effectively implemented in Q4 2022 subject to the fulfillment of certain conditions as part of the SPA.
As of September 20, 2022, The transaction is expected to complete in October.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.73% | 4.01B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
PT KALBE FARMA TBK. 
